Aquaculture for all

Fishmeal replacement now commercially available

Salmonids Nutrition +1 more

The first batch of FeedKind fishmeal replacement to be produced at Calystas new production plant on Teesside is now commercially available for feed manufacturers.

Four tonnes of FeedKind are now up for grabs in order to support market development in the European Union, the United States, Japan, Southeast Asia, China, and Australia. The microbial protein is produced via a continuous fermentation process of a natural microorganism, using the world’s only commercially-validated gas fermentation process. The Teesside plant has met its design parameters, including key commercial metrics such as yield and productivity. The facility has successfully maintained a continuous fermentation for eight weeks, which yielded the first batch.

“We are extremely pleased at the performance of this facility achieving its target metrics quickly, safely and efficiently,” said Graham Aylen, Calysta Vice President of Capital Projects. “This accomplishment has been possible based on the strength of our proprietary technology and the fact that this facility is a scaled-down version of a successful commercial facility.”

Calysta has put state-of-the-art manufacturing and quality assurance processes in place, following over 10 years of research and development on FeedKind protein. The Teesside facility is a scale-down from a reactor demonstrated to produce at a rate of 10,000 tonnes per year. In April 2017, Calysta and Cargill held the ground-breaking of what will be the world’s largest gas fermentation facility in Memphis, Tennessee, to produce FeedKind. Engineering is underway, and the facility is planned to come online in early 2019. It is expected to produce up to 20,000 metric tonnes per year from two full-scale reactors initially, before expanding to up to 200,000 tonnes when operating at full capacity.

“I want to commend our team in the UK for achieving this significant milestone and hitting our facility’s design parameters in a very short timeframe,” said Alan Shaw, Calysta President and CEO. “It is a testament to our team’s extensive experience in continuous fermentation and the power of our proprietary technology. Our customers are now able to benefit from Calysta’s substantial investment in research and manufacturing technology for FeedKind protein over the last decade.”

FeedKind protein is a natural, proprietary, and competitively priced animal feed ingredient. It is a safe, non-animal source of protein approved for sale and use in the EU and has been tested on multiple species, including fish, livestock, and pets.

For sample availability, contact